Compounds > celecoxib

celecoxib and methylnitrosourea

celecoxib has been researched along with methylnitrosourea in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, MC; Badawi, AF; El-Sohemy, A; Lu, S; Zhang, X1
Bosland, MC; Condon, MS; Narayanan, BA; Narayanan, NK; Reddy, BS1
Badawi, AF; Badr, MZ; Eldeen, MB; Liu, Y; Ross, EA1
Bosland, MC; Horton, L; Narayanan, BA; Narayanan, NK; Nargi, D; Randolph, C; Reddy, BS1
Ahlers, I; Ahlersova, E; Bojkova, B; Kajo, K; Kassayova, M; Kubatka, P; Orendas, P; Pec, M1
Gao, Y; Mäkelä, TP; Ristimäki, AP; Udd, L1
Bojková, B; Ekmekcioglu, C; Fedoročko, P; Jäger, W; Jendželovský, R; Kajo, K; Kassayová, M; Kisková, T; Kokošová, N; Kubatka, P; Maier-Salamon, A; Mikeš, J; Orendáš, P; Papčová, Z; Rentsen, E; Svoboda, M; Thalhammer, T1

Other Studies

7 other study(ies) available for celecoxib and methylnitrosourea

ArticleYear
Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.
    Cancer letters, 2002, Oct-08, Volume: 184, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dietary Fats; Dietary Fats, Unsaturated; Dose-Response Relationship, Drug; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Isoenzymes; Mammary Neoplasms, Experimental; Methylnitrosourea; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides

2002
Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Aug-15, Volume: 9, Issue:9

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Carcinogens; Celecoxib; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; DNA; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Immunohistochemistry; Isoenzymes; Male; Methylnitrosourea; Microscopy, Fluorescence; Models, Biological; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrazoles; Rats; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Tumor Suppressor Proteins

2003
Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Cancer research, 2004, Feb-01, Volume: 64, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Carcinogens; Celecoxib; Cell Cycle; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Female; Fluorenes; Isoenzymes; Leucine; Mammary Neoplasms, Experimental; Methylnitrosourea; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Transcription Factors

2004
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Oct-01, Volume: 13, Issue:19

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; ErbB Receptors; Humans; Male; Methylnitrosourea; Prostatic Neoplasms; Pyrazoles; Rats; Rats, Wistar; Receptors, Androgen; Sulfonamides; Sulindac; Testosterone

2007
Celecoxib and melatonin in prevention of female rat mammary carcinogenesis.
    Neoplasma, 2009, Volume: 56, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Celecoxib; Drug Therapy, Combination; Eating; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides

2009
N-methylnitrosourea aggravates gastrointestinal polyposis in Lkb1+/- mice.
    Carcinogenesis, 2013, Volume: 34, Issue:10

    Topics: AMP-Activated Protein Kinases; Animals; Carcinogenesis; Carcinogens; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Gastric Mucosa; Gastrointestinal Neoplasms; Methylnitrosourea; Mice; Mice, Knockout; Peutz-Jeghers Syndrome; Protein Serine-Threonine Kinases; Pyrazoles; Sulfonamides

2013
Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2014, Volume: 23, Issue:6

    Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Celecoxib; Chemoprevention; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Methylnitrosourea; Pyrazoles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfonamides

2014